DE60032704T2 - Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit - Google Patents

Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit Download PDF

Info

Publication number
DE60032704T2
DE60032704T2 DE60032704T DE60032704T DE60032704T2 DE 60032704 T2 DE60032704 T2 DE 60032704T2 DE 60032704 T DE60032704 T DE 60032704T DE 60032704 T DE60032704 T DE 60032704T DE 60032704 T2 DE60032704 T2 DE 60032704T2
Authority
DE
Germany
Prior art keywords
coating
tablet
polymer
membrane
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60032704T
Other languages
German (de)
English (en)
Other versions
DE60032704D1 (de
Inventor
Peter Fyhr
Marta Corselli
Staffan Waxegard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Laboratories UT Inc
Original Assignee
Actavis Laboratories UT Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Laboratories UT Inc filed Critical Actavis Laboratories UT Inc
Application granted granted Critical
Publication of DE60032704D1 publication Critical patent/DE60032704D1/de
Publication of DE60032704T2 publication Critical patent/DE60032704T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60032704T 1999-10-28 2000-10-11 Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit Expired - Fee Related DE60032704T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903879 1999-10-28
SE9903879A SE9903879D0 (sv) 1999-10-28 1999-10-28 Multipor food protection

Publications (2)

Publication Number Publication Date
DE60032704D1 DE60032704D1 (de) 2007-02-15
DE60032704T2 true DE60032704T2 (de) 2007-10-11

Family

ID=20417507

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032704T Expired - Fee Related DE60032704T2 (de) 1999-10-28 2000-10-11 Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit

Country Status (5)

Country Link
EP (1) EP1095651B1 (es)
JP (1) JP4711499B2 (es)
DE (1) DE60032704T2 (es)
ES (1) ES2280192T3 (es)
SE (1) SE9903879D0 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005104914A (ja) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk 塩基性薬剤含有製剤
WO2006080029A1 (en) * 2005-01-27 2006-08-03 Alembic Limited Extended release formulation of levetiracetam
EP1868567A4 (en) * 2005-03-29 2010-09-29 Mcneil Ppc Inc COMPOSITIONS WITH HYDROPHILIC DRUGS IN A HYDROPHOBIC MEDIUM
WO2012166474A1 (en) * 2011-06-01 2012-12-06 Fmc Corporation Controlled release solid dose forms
US9533262B2 (en) 2013-03-14 2017-01-03 Dow Global Technologies Llc Composite polyamide membrane including dissolvable polymer coating
JPWO2022014601A1 (es) * 2020-07-13 2022-01-20

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0211991B1 (en) * 1982-07-08 1989-10-25 Ab Leo Substained release tablets and method for preparation thereof
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
AU675557B2 (en) * 1993-06-14 1997-02-06 Janssen Pharmaceutica N.V. Extended release, film-coated tablet of astemizole and pseudoephedrine
DK171127B1 (da) * 1994-04-22 1996-06-24 Gea Farmaceutisk Fabrik As Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor

Also Published As

Publication number Publication date
JP2001131059A (ja) 2001-05-15
ES2280192T3 (es) 2007-09-16
SE9903879D0 (sv) 1999-10-28
DE60032704D1 (de) 2007-02-15
JP4711499B2 (ja) 2011-06-29
EP1095651B1 (en) 2007-01-03
EP1095651A3 (en) 2002-08-21
EP1095651A2 (en) 2001-05-02

Similar Documents

Publication Publication Date Title
DE19940944B4 (de) Retardierte, orale, pharmazeutische Darreichungsformen
DE69423028T3 (de) Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält
DE60036874T2 (de) Pellet formulierung mit gesteuerter freisetzung
DE69629797T2 (de) Matrix zur gesteuerten freisetzung von arzneistoffen
EP0348808B1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung
EP0977557B1 (de) Pellet-formulierung zur behandlung des intestinaltraktes
DE69632753T2 (de) Darifenacin enthaltende pharmazeutische Zubereitungen
DE60121857T2 (de) Arzneimittelzusammensetzung mit verzögerter Wirkstoffabgabe
DE69721845T2 (de) Orale morphinzubereitung in teilchenform
DE69825165T2 (de) Arzneimittelform mit zwei überzugs-schichten
DE69816951T2 (de) Zubereitung enthaltend Cefaclor oder Cephalexin mit modifizierter Freisetzungsmatrix
EP0520119A1 (de) Neue orale Diclofenaczubereitung
EP1113787B1 (de) Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung
CH641357A5 (de) Pharmazeutisches praeparat mit polymerbeschichtungen, enthaltend herzglykoside.
DE2414868A1 (de) Arzneimittel und verfahren zu seiner herstellung
CH675070A5 (es)
EP1017392B1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
DE3943242A1 (de) Vollstaendiger oder partieller ueberzug von pharmazeutischen wirkstoffen und entsprechende zusammensetzungen
CH705273B1 (de) Pharmazeutische Zusammensetzung – umfassend Hydromorphon und Naloxon.
DE2741755C2 (de) Überzugsmassen auf Polymerbasis für biologisch aktive Präparate, Verfahren zu ihrer Herstellung sowie mit diesen Überzugsmassen überzogene biologisch aktive Präparate und Verfahren zur Herstellung derselben
DE69817848T2 (de) Monolithsysteme enthaltend mindestens einer wirkstoff, bestehend aus drei schichten mit unterschiedlichen freisetzungmechanismus
EP0250648A2 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
EP1315481B1 (de) Arzneimittel zur behandlung von darmerkrankungen
DD209575A5 (de) Verfahren zur herstellung eines pharmazeutischen produktes in anhaltend freisetzender form
DE3909520A1 (de) Feste, schnell zerfallende darreichungsformen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee